107 related articles for article (PubMed ID: 28183747)
21. Lymphocyte predominance Hodgkin's disease: the use of bcl-6 and CD57 in diagnosis and differential diagnosis.
Kraus MD; Haley J
Am J Surg Pathol; 2000 Aug; 24(8):1068-78. PubMed ID: 10935647
[TBL] [Abstract][Full Text] [Related]
22. Lymphocyte depleted Hodgkin lymphoma: an evaluation with immunophenotyping and genetic analysis.
Slack GW; Ferry JA; Hasserjian RP; Sohani AR; Longtine JA; Harris NL; Zukerberg LR
Leuk Lymphoma; 2009 Jun; 50(6):937-43. PubMed ID: 19455461
[TBL] [Abstract][Full Text] [Related]
23. Aberrant expression of Notch1 interferes with the B-lymphoid phenotype of neoplastic B cells in classical Hodgkin lymphoma.
Jundt F; Acikgöz O; Kwon SH; Schwarzer R; Anagnostopoulos I; Wiesner B; Mathas S; Hummel M; Stein H; Reichardt HM; Dörken B
Leukemia; 2008 Aug; 22(8):1587-94. PubMed ID: 18449208
[TBL] [Abstract][Full Text] [Related]
24. Expression patterns of transcription factors in progressively transformed germinal centers and Hodgkin lymphoma.
Steimle-Grauer SA; Tinguely M; Seada L; Fellbaum C; Hansmann ML
Virchows Arch; 2003 Mar; 442(3):284-93. PubMed ID: 12647220
[TBL] [Abstract][Full Text] [Related]
25. [Differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma].
Liu YH; Zhuang HG; Lin HL; Wu QL; Luo DL; Li L; Luo XL
Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):594-8. PubMed ID: 17243292
[TBL] [Abstract][Full Text] [Related]
26. Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma.
Mathas S; Janz M; Hummel F; Hummel M; Wollert-Wulf B; Lusatis S; Anagnostopoulos I; Lietz A; Sigvardsson M; Jundt F; Jöhrens K; Bommert K; Stein H; Dörken B
Nat Immunol; 2006 Feb; 7(2):207-15. PubMed ID: 16369535
[TBL] [Abstract][Full Text] [Related]
27. Differential expression patterns of c-REL protein in classic and nodular lymphocyte predominant Hodgkin lymphoma.
Xiao Q; Shen N; Hedvat CV; Moskowitz CH; Sussman LK; Filippa DA; Zelenetz AD; Houldsworth J; Chaganti RS; Teruya-Feldstein J
Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):211-5. PubMed ID: 15551733
[TBL] [Abstract][Full Text] [Related]
28. Expression of c-FLIP in classic and nodular lymphocyte-predominant Hodgkin lymphoma.
Uherova P; Olson S; Thompson MA; Juskevicius R; Hamilton KS
Appl Immunohistochem Mol Morphol; 2004 Jun; 12(2):105-10. PubMed ID: 15354734
[TBL] [Abstract][Full Text] [Related]
29. Expression of PAX-5 in B Cell Hodgkin and Non Hodgkin Lymphoma.
Khan MR; Ahmad A; Kayani N; Minhas K
Asian Pac J Cancer Prev; 2018 Dec; 19(12):3463-3466. PubMed ID: 30583670
[TBL] [Abstract][Full Text] [Related]
30. Immunology. The yin and yang of follicular helper T cells.
Awasthi A; Kuchroo VK
Science; 2009 Aug; 325(5943):953-5. PubMed ID: 19696339
[No Abstract] [Full Text] [Related]
31. Common activated helper-T-cell origin for lymphomatoid papulosis, mycosis fungoides, and some types of Hodgkin's disease.
Kadin ME
Lancet; 1985 Oct; 2(8460):864-5. PubMed ID: 2413323
[TBL] [Abstract][Full Text] [Related]
32. Cyclin D1 expression and polysomy in lymphocyte-predominant cells of nodular lymphocyte-predominant Hodgkin lymphoma.
Cho BB; Kelting SM; Gru AA; LeGallo RD; Pramoonjago P; Goldin TA; Heitz CT; Aguilera NS
Ann Diagn Pathol; 2017 Feb; 26():10-15. PubMed ID: 28038705
[TBL] [Abstract][Full Text] [Related]
33. Heterogeneity of BCL6 rearrangements in nodular lymphocyte predominant Hodgkin's lymphoma.
Wlodarska I; Stul M; De Wolf-Peeters C; Hagemeijer A
Haematologica; 2004 Aug; 89(8):965-72. PubMed ID: 15339680
[TBL] [Abstract][Full Text] [Related]
34. [Expression of BSAP/CD30 in classic Hodgkin lymphoma using double-staining technique].
Xi YF; Bai WQ; Wang JF; Wang QH; Jiao SL
Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):136-7. PubMed ID: 17493393
[No Abstract] [Full Text] [Related]
35. Immunoarchitectural patterns in nodular lymphocyte predominant Hodgkin lymphoma: pathologic and clinical implications.
Gloghini A; Bosco A; Ponzoni M; Spina M; Carbone A
Expert Rev Hematol; 2015 Apr; 8(2):217-23. PubMed ID: 25487651
[TBL] [Abstract][Full Text] [Related]
36. Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis.
Rao DA; Gurish MF; Marshall JL; Slowikowski K; Fonseka CY; Liu Y; Donlin LT; Henderson LA; Wei K; Mizoguchi F; Teslovich NC; Weinblatt ME; Massarotti EM; Coblyn JS; Helfgott SM; Lee YC; Todd DJ; Bykerk VP; Goodman SM; Pernis AB; Ivashkiv LB; Karlson EW; Nigrovic PA; Filer A; Buckley CD; Lederer JA; Raychaudhuri S; Brenner MB
Nature; 2017 Feb; 542(7639):110-114. PubMed ID: 28150777
[TBL] [Abstract][Full Text] [Related]
37. Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma.
Hartmann S; Döring C; Vucic E; Chan FC; Ennishi D; Tousseyn T; de Wolf-Peeters C; Perner S; Wlodarska I; Steidl C; Gascoyne RD; Hansmann ML
Br J Haematol; 2015 May; 169(3):415-22. PubMed ID: 25644177
[TBL] [Abstract][Full Text] [Related]
38. [Clinicopathologic study of 40 cases of mediastinal tumours of haematopoietic and lymphoid tissues].
Chen DB; Wang Y; Song QJ; Shen DH
Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):376-81. PubMed ID: 22932404
[TBL] [Abstract][Full Text] [Related]
39. T follicular helper and T follicular regulatory cells in colorectal cancer: A complex interplay.
Hetta HF; Elkady A; Yahia R; Meshall AK; Saad MM; Mekky MA; Al-Kadmy IMS
J Immunol Methods; 2020 May; 480():112753. PubMed ID: 32061875
[TBL] [Abstract][Full Text] [Related]
40. J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.
Moore EM; Swerdlow SH; Gibson SE
Hum Pathol; 2017 Oct; 68():47-53. PubMed ID: 28851661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]